Advances in the Management and Treatment of Patients with Previously-Treated Non-Small Cell Lung Cancer

Advances in the Management and Treatment of Patients with Previously-Treated Non-Small Cell Lung Cancer is organized by the AcademicCME.

Program Dates: October 25, 2019 - October 24, 2020

Accreditation:
Credit Designation Statements:
• AcademicCME designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™.
• AcademicCME designates this enduring material for a maximum of 1.0 CNE Contact Hour

Program Overview:
This CME program was derived from content presented at the Eastern Pulmonary Conference 2019 Annual Meeting in Palm Beach, Florida. Drs. Charles Powell and Julie Barta will review the most recent discoveries about non-small cell lung cancer (NSCLC) tumor microenvironment as well as strategies for the treatment and management of NSCLC. The expert faculty will review strategies to incorporate the interprofessional team in order to deliver the most ideal treatment for patients with NSCLC. After completing this CME program, learners will gain insight into current best practices and treatment approaches for individuals with non-small cell lung cancer.

Learning Objectives
• Understand the most recent discoveries about the tumor microenvironment and the role of the immune system in NSCLC
• Evaluate the latest evidence-based data for the management and treatment of NSCLC
• Collaborate as an integrated team in developing individual treatments strategies to provide optimal care for patients with previously-treated NSCLC

Additional details will be posted as soon as information is available.